Literature DB >> 35875282

Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein- Barr Virus Infection.

Heba Yusuf1, Aretha Kou2, Claire Zelinskas2, Girma Ayele3, Johnathan Frunzi2, Rediet Tefera Atalay3, Miriam B Michael4,5.   

Abstract

A rare complication of infectious mononucleosis is immune thrombocytopenic purpura (ITP). The majority of people affected by Epstein-Barr Virus (EBV) are below the age of 30, while ITP is usually seen with peaks of incidence in the elderly and children. The unique case of an otherwise healthy 22-year-old female will be discussed, with an initial presentation of ecchymosis, rash, and epistaxis, and was subsequently found to have severe thrombocytopenia. The diagnosis of primary EBV infection due to EBV was eventually made, responsive to intravenous (IV) Methylprednisolone. It is important to consider primary EBV infection in the differential diagnosis of a patient who presents with acute thrombocytopenia.
Copyright © 2022, Yusuf et al.

Entities:  

Keywords:  immune thrombocytopenic purpura; infectious mononucleosis; primary ebv infection; severe thrombocytopenia; severe thrombocytopenia treatment

Year:  2022        PMID: 35875282      PMCID: PMC9298466          DOI: 10.7759/cureus.26112

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis.

Authors:  Tohru Takahashi; Nanaka Hamasaka; Sayaka Harada; Nobuaki Sugawara; Mitsuru Yoshimoto
Journal:  Am J Hematol       Date:  2007-05       Impact factor: 10.047

3.  Comparative study between chronic immune thrombocytopenia patients and healthy population on Epstein-Barr virus infection status by polymerase chain reaction.

Authors:  Miao Yan; Ying Zhang; Fan Yang; Li Ji; Mangju Wang; Wensheng Wang
Journal:  Expert Rev Hematol       Date:  2020-06-04       Impact factor: 2.929

4.  The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia.

Authors:  Zhong Wu; Jin Zhou; Xiaoxia Wei; Xin Wang; Yongbin Li; Bing Peng; Ting Niu
Journal:  Hematology       Date:  2013-03-22       Impact factor: 2.269

Review 5.  Epstein-Barr virus infectious mononucleosis.

Authors:  Mark H Ebell
Journal:  Am Fam Physician       Date:  2004-10-01       Impact factor: 3.292

6.  Epstein-Barr virus associated with immune thrombocytopenic purpura in childhood: a retrospective study.

Authors:  C C Hsiao
Journal:  J Paediatr Child Health       Date:  2000-10       Impact factor: 1.954

Review 7.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

8.  Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection.

Authors:  Robert Likic; Dusko Kuzmanic
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.